Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Heroic Mastectomy for Chemoresistant Disease: A Complex Decision

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hortobagyi GN, Ames FC, Buzdar AU, et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer. 1988;62:2507–16.

    Article  CAS  Google Scholar 

  2. Bonadonna G, Valagussa P. Combined modality approach for high-risk breast cancer: the Milan Cancer Institute experience. Surg Oncol Clin North Am. 1995;4:701–14.

    Article  CAS  Google Scholar 

  3. Huang E, McNeese MD, Strom EA, et al. Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer. Int J Radiat Oncol Biol Phys. 2002;53:1225–33.

    Article  Google Scholar 

  4. Buchholz TA, Hill BS, Tucker SL, et al. Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy. Cancer J. 2001;7:413–20.

    CAS  PubMed  Google Scholar 

  5. Mamtani A, Sevilimedu V, Vincent A, Morrow M. Local recurrence is frequent after heroic mastectomy for classically inoperable breast cancers. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10764-x.

Download references

Author information

Authors and Affiliations

  1. Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Anita Mamtani MD & Monica Morrow MD

Authors
  1. Anita Mamtani MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Monica Morrow MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anita Mamtani MD.

Ethics declarations

Disclosure

Dr. Monica Morrow has received honoraria from Exact Sciences and Roche.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

ASO Author Reflections offer a brief invited commentary on the article, Local Recurrence Is Frequent After Heroic Mastectomy for Classically Inoperable Breast Cancers. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10764-x.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mamtani, A., Morrow, M. ASO Author Reflections: Heroic Mastectomy for Chemoresistant Disease: A Complex Decision. Ann Surg Oncol 29, 1049–1050 (2022). https://doi.org/10.1245/s10434-021-10834-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-10834-0

Search

Navigation